Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F14%3A10282343" target="_blank" >RIV/00179906:_____/14:10282343 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11160/14:10282343
Výsledek na webu
<a href="http://onlinelibrary.wiley.com/doi/10.1111/jep.12201/full" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/jep.12201/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/jep.12201" target="_blank" >10.1111/jep.12201</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic
Popis výsledku v původním jazyce
Measuring self-reported adherence may contribute to minimizing the risk of therapy failure. Hence, the main aim of the study was to assess the psychometric properties of the Czech version of Medication Adherence Report Scale (MARS-CZ) and its appropriateness for use in long-term statin therapy where goal levels of low-density lipoprotein cholesterol (LDL-c) should be achieved. Anonymous structured interview was performed to determine self-reported adherence by MARS-CZ in outpatients chronically treatedwith statins. At the same time, medication records were reviewed for inclusion of patients into groups of those who achieved and do not achieved LDL-c goal according to cardiovascular risk level. A total of 136 (86.6%) patients completed the interview; mean age was 66.1years; 49.3% were male. The mean score of MARS-CZ was 24.4 and showed positive skewing. Satisfactory internal consistency, strong test-retest reliability and positive correlation with eight-item Morisky Medication Adherenc
Název v anglickém jazyce
Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic
Popis výsledku anglicky
Measuring self-reported adherence may contribute to minimizing the risk of therapy failure. Hence, the main aim of the study was to assess the psychometric properties of the Czech version of Medication Adherence Report Scale (MARS-CZ) and its appropriateness for use in long-term statin therapy where goal levels of low-density lipoprotein cholesterol (LDL-c) should be achieved. Anonymous structured interview was performed to determine self-reported adherence by MARS-CZ in outpatients chronically treatedwith statins. At the same time, medication records were reviewed for inclusion of patients into groups of those who achieved and do not achieved LDL-c goal according to cardiovascular risk level. A total of 136 (86.6%) patients completed the interview; mean age was 66.1years; 49.3% were male. The mean score of MARS-CZ was 24.4 and showed positive skewing. Satisfactory internal consistency, strong test-retest reliability and positive correlation with eight-item Morisky Medication Adherenc
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FR - Farmakologie a lékárnická chemie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Evaluation in Clinical Practice
ISSN
1356-1294
e-ISSN
—
Svazek periodika
20
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
7
Strana od-do
671-677
Kód UT WoS článku
000342806100018
EID výsledku v databázi Scopus
—